785
Participants
Start Date
July 31, 2015
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2030
Cisplatin
Durvalumab
Radiotherapy
St Luke's Hospital, Dublin
St James's Hospital, Dublin
Royal Devon and Exeter Hospital, Exeter
Leicester Royal Infirmary, Leicester
Castle Hill Hospital, Cottingham
Colchester General Hospital, Colchester
Queen's Hospital, Romford
Royal Preston Hospital, Preston
James Cook University Hospital, Middlesbrough
York Hospital, York
Churchill Hospital, Oxford
Weston Park Hospital, Sheffield
Freeman Hospital, Newcastle upon Tyne
Queen Elizabeth Hospital, Birmingham
University Hospital Coventry, Coventry
Newcross Hospital, Wolverhampton
Bradford Royal Infirmary, Bradford
St James's University Hospital, Leeds
Aberdeen Royal Infirmary, Aberdeen
Royal United Hospital, Bath
Belfast City Hospital, Belfast
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital, Cambridge
Velindre Cancer Centre, Cardiff
Cheltenham General Hospital, Cheltenham
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
Aintree University Hospital, Liverpool
North Middlesex Hospital, London
Christie Hospital, Manchester
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral
Norfolk and Norwich University Hospital, Norwich
Nottingham City Hospital, Nottingham
Derriford Hospital, Plymouth
Royal Shrewsbury Hospital, Shrewsbury
Singleton Hospital, Swansea
Musgrove Park Hospital, Taunton
Torbay Hospital, Torquay
Collaborators (1)
AstraZeneca
INDUSTRY
Cancer Trials Ireland
NETWORK
University of Birmingham
OTHER